Trial intelligence / Profile preview

Icatibant for ACE inhibitor-induced angioedema in adults

2014-001213-12Phase 3Completed

Sponsor
Takeda
Start
Jul 2014
Modality
Peptides
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in angioedema comparing Icatibant (Firazyr) with Placebo (2 arms). Started Jul 2014; status: completed.

02

Drugs

icatibant
03

Conditions

angioedema

Beyond the preview

Go deeper on 2014-001213-12.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2014-001213-12.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call